{"altmetric_id":3456365,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:13565496"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6223cf058f610007bb9","authors":["Yoshihide Kii","Tsugutaka Ito"],"doi":"10.1097\/00005344-199705000-00016","endpage":"675","first_seen_on":"2015-02-10T14:46:45+00:00","issns":["0160-2446"],"issue":"5","journal":"Journal of Cardiovascular Pharmacology","last_mentioned_on":1379455896,"links":["http:\/\/dx.doi.org\/10.1097\/00005344-199705000-00016"],"pubdate":"1997-05-01T00:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"670","subjects":["pharmacology","cardiology"],"title":"Effects of 5-HT4-Receptor Agonists, Cisapride, Mosapride Citrate, and Zacopride, on Cardiac Action Potentials in Guinea Pig Isolated Papillary Muscles","type":"article","volume":"29","mendeley_url":"http:\/\/www.mendeley.com\/research\/effects-5ht4receptor-agonists-cisapride-mosapride-citrate-zacopride-cardiac-action-potentials-guinea"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3628371,"mean":4.9417862081361,"rank":817152,"this_scored_higher_than_pct":63,"this_scored_higher_than":2288168,"rank_type":"exact","sample_size":3628371,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":95207,"mean":8.164719471462,"rank":24711,"this_scored_higher_than_pct":72,"this_scored_higher_than":69410,"rank_type":"exact","sample_size":95207,"percentile":72},"this_journal":{"total_number_of_other_articles":871,"mean":1.9935149425287,"rank":37,"this_scored_higher_than_pct":84,"this_scored_higher_than":732,"rank_type":"exact","sample_size":871,"percentile":84},"similar_age_this_journal_3m":{"total_number_of_other_articles":37,"mean":1.6455555555556,"rank":5,"this_scored_higher_than_pct":86,"this_scored_higher_than":32,"rank_type":"exact","sample_size":37,"percentile":86}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":1},"by_discipline":{"Biochemistry, Genetics and Molecular Biology":1}}}},"posts":{"wikipedia":[{"title":"Mosapride","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=573413056#altmetric_citation_7","license":"public","citation_ids":[3456365,3456366],"posted_on":"2013-09-17T22:11:36+00:00","summary":"Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist.","page_url":"http:\/\/en.wikipedia.org\/?curid=13565496","wiki_lang":"en","author":{"name":"MrADHD","url":"http:\/\/en.wikipedia.org\/wiki\/User:MrADHD"}}]}}